Back
Johnson & Johnson Vs. AbbVie Industry Stock Comparison
Sell
47
JNJ
Johnson & Johnson
Last Price:
160.38
Seasonality Move:
3.38%
Buy
66
ABBV
AbbVie
Last Price:
148.14
Seasonality Move:
10.16%
Sell
47
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $160.48. The Score for JNJ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $148.20. The Score for ABBV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $160.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing selling pressure, which indicates risk of future bearish movement.
ABBV Stock Price Chart
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.63 | Sell |
| Relative Strength Index (14 RSI): | 32.34 | Sell |
| Chaikin Money Flow: | -5357586 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (164.69 - 172.95) | Sell |
| Bollinger Bands (100): | (158.54 - 168.94) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 53.2 | Buy |
| Chaikin Money Flow: | 324657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (147.52 - 151.04) | Sell |
| Bollinger Bands (100): | (136.61 - 153.43) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 163.8 | Sell |
| 20-day SMA: | 168.72 | Sell |
| 50-day SMA: | 166.55 | Sell |
| 200-day SMA: | 165.1 | Sell |
| 8-day EMA: | 163.9 | Sell |
| 20-day EMA: | 166.49 | Sell |
| 50-day EMA: | 166.26 | Sell |
| 200-day EMA: | 165.13 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.36 | Buy |
| 20-day SMA: | 149.39 | Sell |
| 50-day SMA: | 143.6 | Buy |
| 200-day SMA: | 150.49 | Sell |
| 8-day EMA: | 147.91 | Buy |
| 20-day EMA: | 147.94 | Buy |
| 50-day EMA: | 145.99 | Buy |
| 200-day EMA: | 146.9 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.02 per share, and an increase next year of $0.88 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.43 per share, an increase next quarter of $0.05 per share, a decrease this year of $2.71 per share, and an increase next year of $0.05 per share.
Johnson & Johnson Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||